UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting RAGE Signaling in Inflammatory Disease

Annual review of medicine, 2018-01, Vol.69 (1), p.349-364

2018

Volltextzugriff (PDF)

Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis

Oncogene, 2017-03, Vol.36 (11), p.1559-1572

2017

Volltextzugriff (PDF)

A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer

Breast cancer research and treatment, 2019-07, Vol.176 (2), p.271-289

2019

Volltextzugriff (PDF)

GREB1 is a critical regulator of hormone dependent breast cancer growth

Breast cancer research and treatment, 2005-07, Vol.92 (2), p.141-149

2005

Volltextzugriff (PDF)

Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays

The Journal of pharmacology and experimental therapeutics, 2001-12, Vol.299 (3), p.849

2001

Volltextzugriff (PDF)

Discovery of Embelin as a Cell-Permeable, Small-Molecular Weight Inhibitor of XIAP through Structure-Based Computational Screening of a Traditional Herbal Medicine Three-Dimensional Structure Database

Journal of medicinal chemistry, 2004-05, Vol.47 (10), p.2430-2440

2004

Volltextzugriff (PDF)

Long-Term Follow-Up for Locally Advanced and Inflammatory Breast Cancer Patients Treated With Multimodality Therapy

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4067-4074

2004

Volltextzugriff (PDF)

Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression

Oncogene, 2015-10, Vol.34 (42), p.5395-5405

2015

Volltextzugriff (PDF)

Endocrine Adjuvant Therapy for Localized Breast Cancer

The New England journal of medicine, 2018-07, Vol.379 (2), p.193-194

Lippman, Marc E

2018

Volltextzugriff (PDF)

RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer

NPJ breast cancer, 2023-07, Vol.9 (1), p.59-59, Article 59

2023

Volltextzugriff (PDF)

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

Breast cancer research and treatment, 2018-02, Vol.167 (3), p.671-686

2018

Volltextzugriff (PDF)

Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism

Prostaglandins, leukotrienes and essential fatty acids, 2003-06, Vol.68 (6), p.387-398

2003

Volltextzugriff (PDF)

erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer

JNCI : Journal of the National Cancer Institute, 1998-09, Vol.90 (18), p.1361-1370

1998

Volltextzugriff (PDF)

(−)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer

Molecular cancer therapeutics, 2005-02, Vol.4 (2), p.197-205

2005

Volltextzugriff (PDF)

Comment on “The lingering mysteries of metastatic recurrence in breast cancer”

British journal of cancer, 2023-02, Vol.128 (3), p.484-485

2023

Volltextzugriff (PDF)

The role of estrogen receptor signaling in suppressing the immune response to cancer

The Journal of clinical investigation, 2021-12, Vol.131 (24), p.1-3

2021

Volltextzugriff (PDF)

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial

Breast cancer research and treatment, 2001, Vol.65 (2), p.125-134

2001

Volltextzugriff (PDF)

New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK

Breast cancer research and treatment, 2006-11, Vol.100 (2), p.237-238

2006

Volltextzugriff (PDF)

Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: The National Cancer Institute randomized trial

Cancer, 2003-08, Vol.98 (4), p.697-702

2003

Volltextzugriff (PDF)

Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation

Breast cancer research and treatment, 2012-08, Vol.134 (3), p.1027-1039

2012

Volltextzugriff (PDF)

Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival

Breast cancer research and treatment, 2021-01, Vol.185 (2), p.331-341

2021

Volltextzugriff (PDF)

Indicators of Lifetime Estrogen Exposure: Effect on Breast Cancer Incidence and Interaction With Raloxifene Therapy in the Multiple Outcomes of Raloxifene Evaluation Study Participants

Journal of clinical oncology, 2001-06, Vol.19 (12), p.3111-3116

2001

Volltextzugriff (PDF)

The Major Pre- and Postmenopausal Estrogens Play Opposing Roles in Obesity-Driven Mammary Inflammation and Breast Cancer Development

Cell metabolism, 2020-06, Vol.31 (6), p.1154-1172.e9

2020

Volltextzugriff (PDF)

Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer

Cancer research (Chicago, Ill.), 2015-11, Vol.75 (22), p.4681-4687

2015

Volltextzugriff (PDF)

Adverse Cardiovascular Events in Cancer Trials: Missing in Action?

Journal of the American College of Cardiology, 2020-02, Vol.75 (6), p.629-631

2020

Volltextzugriff (PDF)

1 – 25 von 1.252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.121)
Mit Volltextzugriff
(965)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Targeting RAGE Signaling in Inflammatory Disease

Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis

A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer

GREB1 is a critical regulator of hormone dependent breast cancer growth

Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays

Discovery of Embelin as a Cell-Permeable, Small-Molecular Weight Inhibitor of XIAP through Structure-Based Computational Screening of a Traditional Herbal Medicine Three-Dimensional Structure Database

Long-Term Follow-Up for Locally Advanced and Inflammatory Breast Cancer Patients Treated With Multimodality Therapy

Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression

Endocrine Adjuvant Therapy for Localized Breast Cancer

RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism

erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer

(−)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer

Comment on “The lingering mysteries of metastatic recurrence in breast cancer”

The role of estrogen receptor signaling in suppressing the immune response to cancer

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial

New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK

Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: The National Cancer Institute randomized trial

Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation

Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival

Indicators of Lifetime Estrogen Exposure: Effect on Breast Cancer Incidence and Interaction With Raloxifene Therapy in the Multiple Outcomes of Raloxifene Evaluation Study Participants

The Major Pre- and Postmenopausal Estrogens Play Opposing Roles in Obesity-Driven Mammary Inflammation and Breast Cancer Development

Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer

Adverse Cardiovascular Events in Cancer Trials: Missing in Action?

Suchergebnisse filtern